首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Vascular cell

缩写:

ISSN:2045-824X

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引109
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Omotinuwe Adepoju,Alvin Wong,Alex Kitajewski et al. Omotinuwe Adepoju et al.
Background: Infantile hemangiomas (IHs) are the most common benign tumor of infancy, yet their pathogenesis is poorly understood. IHs are believed to originate from a progenitor cell, the hemangioma stem cell (HemSC). Rec...
Austin Gurney,Timothy Hoey Austin Gurney
DLL4 is a ligand for the Notch family of receptors. DLL4 has many important functions in normal development and tissue homeostasis, including roles in the immune system, the gastro-intestinal tract, and in vascular development. Because of t...
Minhong Yan Minhong Yan
DLL4-mediated NOTCH1 signaling represents an essential pathway for vascular development and has emerged as an attractive target for angiogenesis-based cancer therapies. However, newly reported toxicity findings raise safety concerns of chro...
Klaus Mross,Annette Frost,Max E Scheulen et al. Klaus Mross et al.
Background: Telatinib (BAY 57-9352) is an orally available, small-molecule inhibitor of vascular endothelial growth factor receptors 2 and 3 (VEGFR-2/-3) and platelet-derived growth factor receptor β tyrosine kinases. ...
Shakil Ahmad,Peter W Hewett,Bahjat Al-Ani et al. Shakil Ahmad et al.
Background: The negative feedback system is an important physiological regulatory mechanism controlling angiogenesis. Soluble vascular endothelial growth factor (VEGF) receptor-1 (sFlt-1), acts as a potent endogenous solu...
Husain A Al-Mubarak,Talal M Alamri,Saif A Aljabab et al. Husain A Al-Mubarak et al.
Background: Current limitations to the experimentation on patients with peripheral arterial disease push the development of different preclinical strategies. We investigated both duration of ischemia and blood flow recove...
Mathews Lisa,Nagaraja Haleagrahara,Srikumar Chakravarthi Mathews Lisa
Background: Coronary artery disease is a global health concern in the present day with limited therapies. Extensive efforts have been devoted to find molecular therapies to enhance perfusion and function of the ischemic m...
Riccardo Caldini,Elena Fanti,Lucia Magnelli et al. Riccardo Caldini et al.
Background: Poly(ADP-Ribose) polymerase (PARP) activity has been demonstrated fundamental in many cellular processes, including DNA repair, cell proliferation and differentiation. In particular, PARP activity has been rec...
Peter C Rae,Richard Dw Kelly,Stuart Egginton et al. Peter C Rae et al.
Background: Endothelial progenitor cells (EPCs) are implicated in a range of pathological conditions, suggesting a natural therapeutic role for EPCs in angiogenesis. However, current angiogenic therapies involving EPC tra...
Rashna D Balsara,Reid Merryman,Farhaad Virjee et al. Rashna D Balsara et al.
The angiogenic potential of a cell requires dynamic reorganization of the cytoskeletal architecture that involves the interaction of urokinase-type plasminogen activator receptor (uPAR) with the extracellular matrix. This study focuses on t...